[Myelodysplastic syndromes].
Raza
A
A
Rush Cancer Institute, Chicago, Illinois, USA.
Vadhan-Raj
S
S
Chávez-Sánchez
G
G
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017209:Apoptosis; D001803:Blood Transfusion; D001853:Bone Marrow / Q000473:pathology; D002986:Clinical Trials as Topic; D002999:Clone Cells / Q000473:pathology; D016207:Cytokines / Q000502:physiology; D004921:Erythropoietin / Q000627:therapeutic use; D006410:Hematopoiesis; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000473:pathology; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000145:classification / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D012176:Retinoids / Q000627:therapeutic use
D016207:Cytokines; D016298:Hematopoietic Cell Growth Factors; D006728:Hormones; D012176:Retinoids; D004921:Erythropoietin